- Home
- FANG vs ALC Comparison
FANG vs ALC Comparison
Compare FANG & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FANG
- ALC
- Stock Information
- Founded
- FANG 2007
- ALC 1945
- Country
- FANG United States
- ALC Switzerland
- Employees
- FANG N/A
- ALC N/A
- Industry
- FANG Oil & Gas Production
- ALC Ophthalmic Goods
- Sector
- FANG Energy
- ALC Health Care
- Exchange
- FANG Nasdaq
- ALC Nasdaq
- Market Cap
- FANG 41.2B
- ALC 46.8B
- IPO Year
- FANG 2012
- ALC N/A
- Fundamental
- Price
- FANG $135.30
- ALC $85.92
- Analyst Decision
- FANG Strong Buy
- ALC Buy
- Analyst Count
- FANG 21
- ALC 10
- Target Price
- FANG $195.14
- ALC $107.00
- AVG Volume (30 Days)
- FANG 2.2M
- ALC 1.9M
- Earning Date
- FANG 05-05-2025
- ALC 05-13-2025
- Dividend Yield
- FANG 3.89%
- ALC 0.39%
- EPS Growth
- FANG N/A
- ALC 6.66
- EPS
- FANG 16.37
- ALC 2.25
- Revenue
- FANG $12,286,000,000.00
- ALC $9,925,000,000.00
- Revenue This Year
- FANG $37.85
- ALC $6.22
- Revenue Next Year
- FANG N/A
- ALC $7.16
- P/E Ratio
- FANG $8.22
- ALC $38.03
- Revenue Growth
- FANG 46.77
- ALC 3.80
- 52 Week Low
- FANG $114.00
- ALC $80.48
- 52 Week High
- FANG $214.50
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- FANG 46.42
- ALC 36.60
- Support Level
- FANG $132.20
- ALC $84.94
- Resistance Level
- FANG $139.22
- ALC $87.64
- Average True Range (ATR)
- FANG 3.13
- ALC 1.64
- MACD
- FANG -0.15
- ALC -0.58
- Stochastic Oscillator
- FANG 23.67
- ALC 9.42
About FANG Diamondback Energy Inc.
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2024, the company reported net proven reserves of 3.6 billion barrels of oil equivalent. Net production averaged about 598,000 barrels per day in 2024, at a ratio of 56% oil, 23% natural gas liquids, and 21% natural gas.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.